- Report
- February 2026
- 383 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 274 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- September 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- August 2025
- 136 Pages
Asia Pacific
From €3022EUR$3,450USD£2,623GBP
- Report
- January 2025
- 167 Pages
Global
From €3897EUR$4,450USD£3,383GBP
- Report
- January 2025
- 25 Pages
India
From €995EUR$1,217USD£894GBP
- Report
- May 2022
- 109 Pages
South Africa
From €2496EUR$2,850USD£2,166GBP
Vicks is a brand of cough and cold drugs, owned by the American company Procter & Gamble. It is one of the most popular over-the-counter medications for treating symptoms of the common cold, such as sore throat, congestion, and cough. Vicks products are available in a variety of forms, including tablets, liquids, and inhalers. The brand also offers a range of products for relieving nasal congestion, such as nasal sprays and decongestants.
Vicks is a well-known brand in the cough and cold drug market, with a wide range of products to suit different needs. It is a trusted brand, with a long history of providing effective relief from cold and flu symptoms.
The cough and cold drug market is highly competitive, with many companies offering similar products. Some of the major players in the market include Johnson & Johnson, GlaxoSmithKline, Novartis, Sanofi, Bayer, and Pfizer. Show Less Read more